Article
Prioritizing Parkinson’s disease risk genes in genome-wide association loci
2024-12-14
Abstract excerpt
Recent advancements in Parkinson’s disease (PD) drug development have been significantly driven by genetic research. Importantly, drugs supported by genetic evidence are more likely to be approved. While genome-wide association studies (GWAS) are a powerful tool to nominate genomic regions associated with certain traits or diseases, pinpointing the causal biologically relevant gene is often challenging. Our aim wa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 01be91e8-7936-5524-bf4e-bf2488d6211e
- DOI
- 10.1101/2024.12.13.24318996
